Lamisil 10 mg/g krema
| Name | Lamisil 10 mg/g krema |
|---|---|
| Former Name | Lamisil 1 % krema |
| Marketing Authorisation Number | HR-H-374155033 |
| Active Substance | terbinafinklorid |
| Composition | 1 g kreme sadrži 10 mg terbinafinklorida, što je ekvivalentno 8,8 mg terbinafina |
| Pharmaceutical Form | krema |
| Manufacturer | GlaxoSmithKline Consumer Healthcare GmbH & Co. KG, München, Njemačka |
| Marketing Authorisation Holder | GlaxoSmithKline Dungarvan Ltd., Knockbrack, Dungarvan, County Waterford, Irska |
| Marketing Authorisation Date | 10.12.2018 |
| MA Period of Validity | unlimited |
| Classification Number | UP/I-530-09/15-02/318 |
| Registration Number | 381-12-01/38-18-25 |
| Prescription | na recept |
| Type of prescription | neponovljivi recept |
| Distribution | u ljekarni |
| Advertising to general public | zabranjeno |
| ATC Code | D01AE15 |
| Medicinal product marketed in the Croatia | Da |
| SmPC | download |
| PL | download |
